Prosecution Insights
Last updated: October 02, 2026

Examiner: WENG, KAI H

Tech Center 3700 • Art Units: 3700 3761 3781

This examiner grants 70% of resolved cases

Analysis

Kai H. Weng has resolved 494 cases in Art Unit 3700, with an allowance rate of 70.2 percent. The median days to allowance is 1224, which is a significant duration. This indicates a steady but somewhat lengthy prosecution process in Tech Center 3700. The 70.2 percent allowance rate is relatively high, suggesting that the examiner is receptive to patentable subject matter despite the 1224-day timeline.

The interview lift of 17.2 percent suggests that verbal discussion is a helpful supplement to written arguments. It increases the 70.2 percent baseline, providing a better chance of reaching an allowance. Practitioners should plan for a longer timeline but can expect a generally receptive examiner. The 17.2 percent lift indicates that interviews are a useful tool for clarifying complex issues and moving cases forward. With 494 resolved cases, the examiner's history is well-documented and shows a consistent approach to examination. Applicants who engage in proactive communication and provide thorough responses are likely to find success in this docket, even if it takes 1224 days to reach a grant. The data supports a strategy of both written and verbal advocacy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

70.2%
Allow Rate
At TC average
529
Total Applications
+17.2%
Interview Lift
1224
Avg Prosecution Days
Based on 494 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
13.8%
§102 Novelty
59.1%
§103 Obviousness
16.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18801994 RFID TAG FOR EXPANDED CAPABILITIES OF A THROMBECTOMY SYSTEM Non-Final OA Boston Scientific Scimed, Inc.
18741992 MEDICAL SYSTEMS, DEVICES, AND RELATED METHODS FOR WOUND THERAPY Non-Final OA Boston Scientific Scimed, Inc.
18741950 ENDOLUMINAL TREATMENT DEVICES Non-Final OA Boston Scientific Scimed, Inc.
18495846 ARRAY OF ABSORBENT ARTICLES HAVING WAIST GASKETING ELEMENTS Final Rejection The Procter & Gamble Company
18233204 MEDICAL SHUNTS Final Rejection THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
18762068 ACUTE GLAUCOMA DEVICE Non-Final OA Alcon Inc.
17064241 Plastic Jacket for Vial Labeling Systems Final Rejection Allogene Therapeutics, Inc.
18802787 SHUNT IMPLANT WITH ADJUSTABLE BARREL Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18710007 AMPOULE FOR ORAL VACCINE ADMINISTRATION AND METHODS OF USE Non-Final OA Merck Sharp & Dohme LLC
18805986 METHOD AND APPARATUS FOR PROVIDING NEGATIVE PRESSURE TO A NEGATIVE PRESSURE WOUND THERAPY BANDAGE Non-Final OA Smith & Nephew, Inc.
17996748 DRAINAGE SHUNT DEVICES AND METHODS FOR DRAINING ASCITES FLUID FROM PERITONEAL CAVITIES Non-Final OA CareFusion 2200, Inc.
18436370 BIOLOGICAL FLUID DRAINAGE DEVICES AND METHODS Non-Final OA W. L. Gore & Associates, Inc.
17953562 CATHETER AND CATHETER SYSTEM Non-Final OA TERUMO KABUSHIKI KAISHA
17979907 CONTAINER AND SYSTEM FOR RECONSTITUTION AND ADMINISTRATION OF DRUGS Final Rejection B. Braun Medical Inc.
18557328 A BODY-CONFORMING DISPOSABLE PANT-TYPE ARTICLE Final Rejection Essity Hygiene and Health Aktiebolag
18715854 ENVIRONMENTALLY-FRIENDLY ABSORBENT ARTICLE AND PROCESS OF MAKING Non-Final OA ONTEX GROUP NV
18974367 USING WICKING MATERIAL TO COLLECT LIQUID FOR TRANSPORT Non-Final OA PUREWICK CORPORATION
16979867 METHODS FOR DETERMINING FUTURE OPERATING STATES AND RELATED ACCESSORY DEVICES OF A MEDICAL SYSTEM, AND MEDICAL SYSTEMS Final Rejection Coloplast A/S
18705394 MODULAR THERAPY DEVICES AND POWERED CONSUMABLES WITH DISPOSAL FEATURES FOR REDUCED ENVIRONMENTAL IMPACT Non-Final OA KCI Manufacturing Unlimited Company

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month